{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:34:00Z","timestamp":1783758840744,"version":"3.55.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["32003B-134963\/1"],"award-info":[{"award-number":["32003B-134963\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA009789"],"award-info":[{"award-number":["DA009789"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.tips.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T08:02:07Z","timestamp":1334304127000},"page":"331-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction"],"prefix":"10.1016","volume":"33","author":[{"given":"Fabrizio","family":"Montecucco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2012.03.002_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phrs.2009.02.010","article-title":"The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation","volume":"60","author":"Di Marzo","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tips.2012.03.002_bib0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrd2553","article-title":"Targeting the endocannabinoid system: to enhance or reduce?","volume":"7","author":"Di Marzo","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2012.03.002_bib0015","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1002\/j.1552-4604.2002.tb06004.x","article-title":"Cardiovascular system effects of marijuana","volume":"42","author":"Jones","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0020","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0022-3565(24)36714-X","article-title":"Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors","volume":"281","author":"Lake","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2012.03.002_bib0025","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s001090050287","article-title":"Cardiovascular actions of cannabinoids and their generation during shock","volume":"76","author":"Wagner","year":"1998","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.tips.2012.03.002_bib0030","doi-asserted-by":"crossref","first-page":"H533","DOI":"10.1152\/ajpheart.00107.2005","article-title":"Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase","volume":"289","author":"Pacher","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00210-001-0498-6","article-title":"Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats","volume":"364","author":"Malinowska","year":"2001","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.03.002_bib0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature02282","article-title":"Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1","volume":"427","author":"Jordt","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.03.002_bib0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1464793103006201","article-title":"Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling","volume":"79","author":"Hiley","year":"2004","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.tips.2012.03.002_bib0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01112-8","article-title":"Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors","volume":"423","author":"Wagner","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0060","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2012.03.002_bib0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/jpet.106.112904","article-title":"Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet","volume":"321","author":"Wang","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2012.03.002_bib0070","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.2004.051599","article-title":"Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors","volume":"54","author":"Domenicali","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.tips.2012.03.002_bib0075","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1523\/JNEUROSCI.23-31-10146.2003","article-title":"Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting Ih","volume":"23","author":"Ray","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2012.03.002_bib0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.tips.2012.03.002_bib0085","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1478-3231.2007.01551.x","article-title":"Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis","volume":"27","author":"Yang","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.tips.2012.03.002_bib0090","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.HYP.35.2.679","article-title":"Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice","volume":"35","author":"J\u00e1rai","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2012.03.002_bib0095","doi-asserted-by":"crossref","first-page":"H2363","DOI":"10.1152\/ajpheart.01042.2007","article-title":"Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries","volume":"294","author":"Awumey","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.bjp.0705643","article-title":"Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)","volume":"141","author":"O'Sullivan","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/3-540-26573-2_20","article-title":"Cardiovascular pharmacology of cannabinoids","volume":"168","author":"Pacher","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0110","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.chembiol.2010.08.013","article-title":"Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects","volume":"17","author":"Godlewski","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tips.2012.03.002_bib0115","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.0510676103","article-title":"N-Arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties","volume":"103","author":"Milman","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2012.03.002_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2091-10-14","article-title":"The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways","volume":"10","author":"Bradshaw","year":"2009","journal-title":"BMC Biochem."},{"key":"10.1016\/j.tips.2012.03.002_bib0125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1476-5381.2009.00622.x","article-title":"N-Arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels","volume":"160","author":"Parmar","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1113\/jphysiol.2005.094292","article-title":"Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed","volume":"568","author":"Poblete","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-11-44","article-title":"N-Arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor","volume":"11","author":"McHugh","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.tips.2012.03.002_bib0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"\u2018Entourage\u2019 effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors","volume":"155","author":"Ho","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0145","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejphar.2011.11.033","article-title":"Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries","volume":"674","author":"Wheal","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bjp.0707421","article-title":"GPR55 and the vascular receptors for cannabinoids","volume":"152","author":"Hiley","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0155","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0707419","article-title":"The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects","volume":"152","author":"Johns","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1113\/jphysiol.2004.064824","article-title":"Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice","volume":"558","author":"Pacher","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0165","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1096\/fj.06-7451com","article-title":"Cannabinoid-2 receptor mediates protection against hepatic ischemia\/reperfusion injury","volume":"21","author":"B\u00e1tkai","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2012.03.002_bib0170","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2007.03.057","article-title":"Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity","volume":"50","author":"Mukhopadhyay","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0705313","article-title":"Endocannabinoids protect the rat isolated heart against ischaemia","volume":"139","author":"L\u00e9picier","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3580249","article-title":"Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells","volume":"358","author":"Di Marzo","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.tips.2012.03.002_bib0190","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bjp.0703902","article-title":"Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide","volume":"132","author":"Lagneux","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0195","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0008-6363(02)00268-7","article-title":"Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts","volume":"55","author":"Joyeux","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2012.03.002_bib0200","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.yjmcc.2008.12.014","article-title":"CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia\/reperfusion","volume":"46","author":"Montecucco","year":"2009","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0205","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1096\/fj.09-129478","article-title":"The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia\/reperfusion-induced cardiomyopathy","volume":"23","author":"Defer","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2012.03.002_bib0210","doi-asserted-by":"crossref","first-page":"H610","DOI":"10.1152\/ajpheart.00236.2007","article-title":"Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0215","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0220","doi-asserted-by":"crossref","first-page":"H3602","DOI":"10.1152\/ajpheart.00098.2007","article-title":"Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury","volume":"293","author":"Durst","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0225","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0230","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/ATVBAHA.110.206011","article-title":"Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice","volume":"30","author":"Montecucco","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2012.03.002_bib0235","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1476-5381.2010.00755.x","article-title":"Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion","volume":"160","author":"Walsh","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.yjmcc.2009.07.011","article-title":"Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner","volume":"48","author":"Amor\u00f3s","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0245","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1742-1241.2007.01505.x","article-title":"Atrial fibrillation and marijuana smoking","volume":"62","author":"Korantzopoulos","year":"2008","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.tips.2012.03.002_bib0250","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-induced cardiomyopathy","volume":"339","author":"Singal","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2012.03.002_bib0255","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-009-0051-8","article-title":"Cardiomyocyte death in doxorubicin-induced cardiotoxicity","volume":"57","author":"Zhang","year":"2009","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.tips.2012.03.002_bib0260","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1074248408329449","article-title":"Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model","volume":"14","author":"Hydock","year":"2009","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2012.03.002_bib0265","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2010.11.002","article-title":"Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury","volume":"50","author":"Mukhopadhyay","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tips.2012.03.002_bib0270","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/cvr\/cvp369","article-title":"CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes","volume":"85","author":"Mukhopadhyay","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2012.03.002_bib0275","doi-asserted-by":"crossref","DOI":"10.1111\/j.1478-3231.2011.02751.x","article-title":"Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis","author":"Theocharidou","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.tips.2012.03.002_bib0280","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/89953","article-title":"Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis","volume":"7","author":"B\u00e1tkai","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2012.03.002_bib0285","doi-asserted-by":"crossref","first-page":"H1689","DOI":"10.1152\/ajpheart.00538.2007","article-title":"Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats","volume":"293","author":"B\u00e1tkai","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0290","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.bjp.0706332","article-title":"Cirrhotic cardiomyopathy: an endocannabinoid connection?","volume":"146","author":"Pacher","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0295","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2010.03.011","article-title":"Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids","volume":"53","author":"Yang","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tips.2012.03.002_bib0300","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1478-3231.2007.01493.x","article-title":"Quantitative ultrasonic tissue characterization as a new tool for continuous monitoring of chronic liver remodelling in mice","volume":"27","author":"Guimond","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.tips.2012.03.002_bib0305","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/sj.bjp.0706928","article-title":"Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptors","volume":"149","author":"Moezi","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0310","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2012.03.002_bib0315","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2012.03.002_bib0320","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.299.13.1547","article-title":"Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2012.03.002_bib0325","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrendo.2009.197","article-title":"CB1 antagonists for obesity \u2013 what lessons have we learned from rimonabant?","volume":"5","author":"Di Marzo","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tips.2012.03.002_bib0330","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.molmed.2011.05.002","article-title":"Energy balance regulation by endocannabinoids at central and peripheral levels","volume":"17","author":"Quarta","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tips.2012.03.002_bib0335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-642-17214-4_4","article-title":"Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes","volume":"203","author":"Di Marzo","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0340","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2008.12.040","article-title":"Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis","volume":"205","author":"Montecucco","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tips.2012.03.002_bib0345","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/ATVBAHA.108.168757","article-title":"Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice","volume":"29","author":"Dol-Gleizes","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2012.03.002_bib0350","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00395-010-0090-7","article-title":"CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function","volume":"105","author":"Tiyerili","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0355","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00125-008-1178-6","article-title":"Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors","volume":"52","author":"Di Marzo","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2012.03.002_bib0360","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/eurheartj\/ehr029","article-title":"Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity","volume":"32","author":"Quercioli","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2012.03.002_bib0365","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.811992","article-title":"Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages","volume":"119","author":"Sugamura","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2012.03.002_bib0370","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/bj3460835","article-title":"Functional CB1 cannabinoid receptors in human vascular endothelial cells","volume":"346","author":"Liu","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.tips.2012.03.002_bib0375","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.00712.x","article-title":"Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells","volume":"160","author":"Rajesh","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0380","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvp240","article-title":"CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages","volume":"84","author":"Han","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2012.03.002_bib0385","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbrc.2008.10.159","article-title":"Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation","volume":"377","author":"Rajesh","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2012.03.002_bib0390","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1253\/circj.CJ-11-0366","article-title":"Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy","volume":"75","author":"Curcio","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.tips.2012.03.002_bib0395","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00125-011-2061-4","article-title":"Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line","volume":"54","author":"El-Remessy","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2012.03.002_bib0400","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2337\/db11-0477","article-title":"Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy","volume":"61","author":"Rajesh","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2012.03.002_bib0405","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajpath.2011.11.003","article-title":"The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications","volume":"180","author":"Horv\u00e1th","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2012.03.002_bib0410","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1472-8206.2009.00679.x","article-title":"Increased serum anandamide level at ruptured plaque site in patients with acute myocardial infarction","volume":"23","author":"Maeda","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0415","doi-asserted-by":"crossref","first-page":"H1145","DOI":"10.1152\/ajpheart.01328.2007","article-title":"CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways","volume":"294","author":"Montecucco","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0420","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","article-title":"CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0425","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.yjmcc.2011.08.008","article-title":"Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo","volume":"51","author":"Hoyer","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0430","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.03.002_bib0435","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2010.07.060","article-title":"Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice","volume":"213","author":"Netherland","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tips.2012.03.002_bib0440","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1874192401105010015","article-title":"Cannabinoid receptor 2 deficiency in haematopoietic cells aggravates early atherosclerosis in LDL receptor deficient mice","volume":"5","author":"Delsing","year":"2011","journal-title":"Open Cardiovasc. Med. J."},{"key":"10.1016\/j.tips.2012.03.002_bib0445","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bjp.0707569","article-title":"CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration","volume":"153","author":"Rajesh","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.002_bib0450","doi-asserted-by":"crossref","first-page":"H1064","DOI":"10.1152\/ajpheart.00444.2011","article-title":"The cannabinoid receptor CB2 protects against balloon-induced neointima formation","volume":"312","author":"Molica","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2012.03.002_bib0455","article-title":"The activation of the cannabinoid receptor type 2 (CB2) reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques","author":"Montecucco","year":"2011","journal-title":"Eur. Heart J."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561471200034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561471200034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:05:37Z","timestamp":1759050337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016561471200034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S016561471200034X"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2012.03.002","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2012.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}